All agreed.
More over facility in USA has ability to expand by 3 times if need be.
The way i am looking at MYX is that its generics can and will recover and it can grow to have lot of muscle there .In the menatime its speciality business will grow multifold to provide a solid base as well as a back bone.
When new additions come in and start delivering along with generic of Nuvaring , it will be a very different story.
Giving it 12-18 months more at the most will be enough in my opinion.
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.07 |
Change
0.050(1.00%) |
Mkt cap ! $411.9M | |||
| Open | High | Low | Value | Volume |
| $5.00 | $5.14 | $4.94 | $712.4K | 141.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1059 | $5.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.13 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |